US SB670 | 2021-2022 | 117th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 10 2021 - 25% progression, died in committee
Action: 2021-03-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 10 2021 - 25% progression, died in committee
Action: 2021-03-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to accelerate development of therapies across the spectrum of rare diseases and conditions and facilitate patient access to such therapies, and for other purposes.
Title
Speeding Therapy Access Today Act of 2021
Sponsors
Sen. Amy Klobuchar [D-MN] | Sen. Roger Wicker [R-MS] |
History
Date | Chamber | Action |
---|---|---|
2021-03-10 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB1730 (Same As) 2021-03-10 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/senate-bill/670/all-info |
Text | https://www.congress.gov/117/bills/s670/BILLS-117s670is.pdf |